Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   HTML views PDF downloads Totals
14,519 Dovepress* 10,247+ 1,608 11,855
PubMed Central* 4,272 1,054 5,326
Totals 14,519 2,662 17,181
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar